# Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)

Study · id `cardio:ct-nct02520180` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02520180](<https://clinicaltrials.gov/study/NCT02520180>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02520180

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1653 participants.

## Technical summary

Registry record NCT02520180. Randomized; no masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2016-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1653 participants (enrolled count; ClinicalTrials.gov record NCT02520180, source copy `cardio:ctgov-nct02520180-2023-10-23`, retrieved 2026-10-26)
- Started: 2015-12 (actual) (ClinicalTrials.gov record NCT02520180, source copy `cardio:ctgov-nct02520180-2023-10-23`, retrieved 2026-10-26)
- Primary completion: 2016-10 (actual) (ClinicalTrials.gov record NCT02520180, source copy `cardio:ctgov-nct02520180-2023-10-23`, retrieved 2026-10-26)
- Completion: 2022-06 (actual) (ClinicalTrials.gov record NCT02520180, source copy `cardio:ctgov-nct02520180-2023-10-23`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT02520180, source copy `cardio:ctgov-nct02520180-2023-10-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02520180-2023-10-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)
- Condition: Coronary Artery Disease
- Intervention (Device): Firehawk™ stent system
- Intervention (Device): Abbott Xience family Everolimus-Eluting Stent
- Lead sponsor: Shanghai MicroPort Medical (Group) Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. (`cardio:org-shanghai-microport-medical-group-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial (`cardio:pubmed-30190206`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: 2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent (`cardio:pubmed-31129092`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: cf10b65ec525afc6c1489abd373030316b26c143c04b5ee8b00d301734b6dc21
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
